Forsta Ap Fonden Abiomed Inc Transaction History

Forsta Ap Fonden

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 17, 2022	SELL	$242.49 - $301.46 $315,237 - $391,898	-1,300 Reduced 10.83%	10,700 $2.63 Million
Q2 2022 Aug 11, 2022	SELL	$224.73 - $338.64 $44,946 - $67,728	-200 Reduced 1.64%	12,000 $2.97 Million
Q1 2022 May 09, 2022	SELL	$277.25 - $366.29 $499,050 - $659,322	-1,800 Reduced 12.86%	12,200 $4.04 Million
Q4 2021 Feb 11, 2022	BUY	$300.63 - $371.35 $962,016 - $1.19 Million	3,200 Added 29.63%	14,000 $5.03 Million
Q3 2021 Nov 10, 2021	BUY	$310.19 - $376.2 $3.35 Million - $4.06 Million	10,800 New	10,800 $3.52 Million
Q1 2021 May 11, 2021	SELL	$285.92 - $355.13 $2.46 Million - $3.05 Million	-8,600 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$251.88 - $324.2 $503,760 - $648,400	2,000 Added 30.3%	8,600 $2.79 Million
Q3 2020 Oct 22, 2020	BUY	$255.22 - $317.0 $178,654 - $221,900	700 Added 11.86%	6,600 $1.83 Million
Q2 2020 Aug 11, 2020	BUY	$141.4 - $257.09 $834,260 - $1.52 Million	5,900 New	5,900 $1.43 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

Stay updated on Forsta Ap Fonden with notifications on news.